Hemostemix Inc.
HMTXF
$0.05
$0.00-4.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 349.10K | 268.40K | 152.90K | 985.00K | 289.30K |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 355.60K | 464.40K | 1.65M | 1.28M | 291.30K |
| Operating Income | -355.60K | -464.40K | -1.65M | -1.28M | -291.30K |
| Income Before Tax | -445.30K | -568.10K | -1.88M | -361.40K | -165.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -445.30K | -568.10K | -1.88M | -361.40K | -165.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -445.30K | -568.10K | -1.88M | -361.40K | -165.30K |
| EBIT | -355.60K | -464.40K | -1.65M | -1.28M | -291.30K |
| EBITDA | -355.60K | -464.40K | -1.65M | -1.28M | -291.20K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 204.99M | 163.44M | 217.80M | 146.47M | 146.47M |
| Average Diluted Shares Outstanding | 204.99M | 163.44M | 217.80M | 146.47M | 146.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |